BD MAX™ ENTERIC PARASITE PANEL - COFEPRIS Registration 1538R2018 SSA
Access comprehensive regulatory information for BD MAX™ ENTERIC PARASITE PANEL (BD MAX™ ENTERIC PARASITE PANEL) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1538R2018 SSA and manufactured by BECTON DICKINSON DE MÉXICO, S.A. DE C.V.. The device was registered on June 14, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
PRUEBA DIAGNÓSTICA IN VITRO AUTOMATIZADA PARA LA DETECCIÓN CUALITATIVA DIRECTA DE PATÓGENOS PARASITARIOS INTESTINALES. LA PRUEBA BD MAX ENTERIC PARASITE PANEL DETECTA LOS ÁCIDOS NUCLEICOS DE: • GIARDIA LAMBLIA • CRYPTOSPORIDIUM (C. HOMINIS Y C. PARVU
AUTOMATED IN VITRO DIAGNOSTIC TEST FOR DIRECT QUALITATIVE DETECTION OF INTESTINAL PARASITIC PATHOGENS. THE BD MAX ENTERIC PARASITE PANEL TEST DETECTS NUCLEIC ACIDS FROM: • GIARDIA LAMBLIA • CRYPTOSPORIDIUM (C. HOMINIS AND C. PARVU